NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球婦產科診察市場:用途,終端用戶,及各地區預測(2019年∼2026年)

Global Women's Health Diagnostics Market Size study, by Application, by End User and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 923395
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球婦產科診察市場:用途,終端用戶,及各地區預測(2019年∼2026年) Global Women's Health Diagnostics Market Size study, by Application, by End User and Regional Forecasts 2019-2026
出版日期: 2020年01月20日內容資訊: 英文
簡介

全球婦產科診察市場在2018年估算為約280億美金。該市場在2019年∼2026年間,預測將以超越7.9%以上的順利的成長率擴大。女性的健康檢查檢驗中,包含妊娠及排卵檢驗,乳癌檢驗,卵巢癌症篩檢等各種檢驗,女性的健康相關障礙的增加帶動該市場。還有新興市場改善醫療保健基礎設施,法規當局對免疫測量診斷技術的認證增加,在預測期間內預計市場有很大的成長機會。可是,高成本的影像診斷系統,熟練的人力資源不足妨礙市場成長。

本報告提供全球婦產科診察市場的相關調查,市場機會,課題及趨勢,成長要素,各用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 市場估計及預測:世界/各市場區隔
  • 主要趨勢
  • 估計方法
  • 調查的前提條件

第2章 市場定義及範圍

  • 調查的目的
  • 市場定義、範圍
    • 調查範圍
    • 產業的發展
  • 調查考慮年份
  • 匯率

第3章 市場動態

  • 市場影響分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的建議、結論

第5章 市場分析:各用途

  • 市場概述
  • 市場成果:潛在力分析
  • 市場估計、預測
  • 子區隔分析
    • 產前檢查
    • 唐氏症
    • 妊娠能力實驗
    • 妊娠檢驗
    • 泌尿道感染
    • 骨質疏鬆症
    • 乳癌檢驗
    • 子宮頸癌症篩檢
    • 卵巢癌症篩檢

第6章 市場分析:各終端用戶

  • 市場概述
  • 市場成果:潛在力分析
  • 市場估計、預測
  • 子區隔分析
    • 醫院
    • 居家護理

第7章 市場分析:各地區

  • 市場概述
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第8章 競爭情形

  • 主要市場策略
  • 企業簡介
    • Siemens AG
    • Quest Diagnostics Inc.
    • Hologic, Inc.
    • F. Hoffmann-La Roche AG
    • Perkinelmer Inc.
    • Alere Inc.
    • GE Healthcare
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • Biomerieux SA

第9章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 調查屬性
  • 調查的前提條件
目錄

Global Women's Health Diagnostics Market is valued approximately USD 28 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.9% over the forecast period 2019-2026. Women are more susceptible to certain diseases, usually related to depression, osteoporosis, menstrual disorders, obesity, and autoimmune diseases. Women's major health concerns are associated with the procreative system that incorporates polycystic ovarian syndrome, infertility, menopause and cancers such as cervical cancer, breast cancer, and urological disorders. As per the, National Institute of Health (NIH), about 40% of women deals with at least one UTI (urinary tract infection) in their lifetime. Further, as per the source, women are 30 times more likely than men to develop a UTI under the age of 50. Moreover, according to the study conducted by University of Chicago (2018), the rate of urinary incontinence is more in 60 & above-aged females which are estimated approximately 69% globally due to geriatric syndrome with age-related changes in physiology, comorbidity, medications and especially functional impairments. High incidence of infectious diseases in women coupled with rising number of chronic and lifestyle-related syndromes in women is increasing the adoption of diagnostics imaging procedures. These women's health diagnostic tests involve various tests such as pregnancy and ovulation tests, breast cancer tests, ovarian cancer tests, and others. Thus, increasing number of women's health related disorder is driving the market. Furthermore, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for immunoassay diagnostic techniques is expected to create significant growth opportunity in the market over the forecast period. However, lack of a skilled workforce coupled with high cost of diagnostic imaging systems impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Women's Health Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing prevalence of cancer among women coupled with the increasing incidences of lifestyle-oriented health disorders. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about women's health disorder, government initiative and improving healthcare infrastructure would create lucrative growth prospects for the Women's Health Diagnostics market across Asia-Pacific region.

Major market player included in this report are:

Siemens AG

Quest Diagnostics Inc.

Hologic, Inc.

F. Hoffmann-La Roche AG

Perkinelmer Inc.

Alere Inc.

GE Healthcare

Becton, Dickinson and Company

Abbott Laboratories

Biomerieux SA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Prenatal Testing,

Down Syndrome

Fertility Test Pregnancy Test,

Urinary Tract Infections,

Osteoporosis,

Breast cancer testing

Cervical cancer testing

Ovarian Cancer Test

By End User:

Hospitals

Home care

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Women's Health Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Women's Health Diagnostics Market, by Region, 2017-2026 (USD Billion)
    • 1.2.2. Women's Health Diagnostics Market, by Application, 2017-2026 (USD Billion)
    • 1.2.3. Women's Health Diagnostics Market, by End- User, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Women's Health Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Diagnostics Market Dynamics

  • 3.1. Women's Health Diagnostics Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Women's Health Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Women's Health Diagnostics Market, by Application

  • 5.1. Market Snapshot
  • 5.2. Global Women's Health Diagnostics Market by Application, Performance - Potential Analysis
  • 5.3. Global Women's Health Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
  • 5.4. Women's Health Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Prenatal Testing
    • 5.4.2. Down Syndrome
    • 5.4.3. Fertility Test
    • 5.4.4. Pregnancy Test
    • 5.4.5. Urinary Tract Infections
    • 5.4.6. Osteoporosis
    • 5.4.7. Breast cancer testing
    • 5.4.8. Cervical cancer testing
    • 5.4.9. Ovarian Cancer Test

Chapter 6. Global Women's Health Diagnostics Market, by End -User

  • 6.1. Market Snapshot
  • 6.2. Global Women's Health Diagnostics Market by End User, Performance - Potential Analysis
  • 6.3. Global Women's Health Diagnostics Market Estimates & Forecasts by End User 2016-2026 (USD Billion)
  • 6.4. Women's Health Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Hospital
    • 6.4.2. Home care

Chapter 7. Global Women's Health Diagnostics Market, Regional Analysis

  • 7.1. Women's Health Diagnostics Market, Regional Market Snapshot
  • 7.2. North America Women's Health Diagnostics Market
    • 7.2.1. U.S. Women's Health Diagnostics Market
      • 7.2.1.1. Application breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. End- User breakdown estimates & forecasts, 2016-2026
    • 7.2.2. Canada Women's Health Diagnostics Market
  • 7.3. Europe Women's Health Diagnostics Market Snapshot
    • 7.3.1. U.K. Women's Health Diagnostics Market
    • 7.3.2. Germany Women's Health Diagnostics Market
    • 7.3.3. Rest of Europe Women's Health Diagnostics Market
  • 7.4. Asia-Pacific Women's Health Diagnostics Market Snapshot
    • 7.4.1. China Women's Health Diagnostics Market
    • 7.4.2. India Women's Health Diagnostics Market
    • 7.4.3. Japan Women's Health Diagnostics Market
    • 7.4.4. Rest of Asia Pacific Women's Health Diagnostics Market
  • 7.5. Latin America Women's Health Diagnostics Market Snapshot
    • 7.5.1. Brazil Women's Health Diagnostics Market
    • 7.5.2. Mexico Women's Health Diagnostics Market
  • 7.6. Rest of The World Women's Health Diagnostics Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Siemens AG
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Quest Diagnostics Inc.
    • 8.2.3. Hologic, Inc.
    • 8.2.4. F. Hoffmann-La Roche AG
    • 8.2.5. Perkinelmer Inc.
    • 8.2.6. Alere Inc.
    • 8.2.7. GE Healthcare
    • 8.2.8. Becton, Dickinson and Company
    • 8.2.9. Abbott Laboratories
    • 8.2.10. Biomerieux SA

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET
  • TABLE 3. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END- USER 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 21. U.S. WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 24. CANADA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. UK WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. UK WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 27. UK WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. ROE WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. ROE WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. ROE WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. CHINA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. INDIA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. ROAPAC WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. ROLA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. ROLA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. ROLA WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROW WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 56. ROW WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. ROW WOMEN'S HEALTH DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA WOMEN'S HEALTH DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC WOMEN'S HEALTH DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA WOMEN'S HEALTH DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL WOMEN'S HEALTH DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)